14-day Premium Trial Subscription Try For FreeTry Free

4 Brand-Name Stocks to Avoid Like the Plague

06:06am, Thursday, 29'th Oct 2020
Popular companies don't always make for profitable stocks.
Kodak stock has been volatile, as it was thrust from irrelevance to the front pages. But this is a no-touch for us.
If a picture can speak a thousand words, the price chart in Kodak stock is warning investors to run in the other direction The post Kodak Stock Remains a Developing Tale of Caution appeared first on I

Air Liquide – Q3 2020 Revenue

12:00am, Friday, 23'rd Oct 2020
Regulatory News: Air Liquide (Paris:AI): Key Figures (in millions of euros) Q3 2020 2020/2019 as published 2020/2019 comparable (a) Group Revenue 4,98

3 Reasons to Sell Eastman Kodak Now

10:12am, Thursday, 22'nd Oct 2020
Here's why the one-time camera giant is unlikely to find redemption via the pharmaceutical industry.
IBM Retirement Fund grew its holdings in Eastman Chemical (NYSE:EMN) by 39.0% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission.
Pacer Advisors Inc. trimmed its stake in shares of Eastman Chemical (NYSE:EMN) by 11.4% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC).
Kodak stock is still hovering at a relatively rich premium due to hopes of a government-sponsored recovery. But this narrative is risky.
An exhibition at the Museum of Modern Art brings together 200 short films, from home movies to experimental works.
Technically speaking, the major U.S. benchmarks continue to digest an October breakout amid still bullish bigger-picture price action, writes Michael Ashbaugh.
The Global Photo Printing and Merchandise Market will grow by USD 4.68 bn during 2020-2024
Eastman Kodak’s Jim Continenza defended his company’s handling of a halted $765 million U.S. loan, though he conceded his company has been understaffed, particularly amid the coronavirus pandemic.
Eastman Kodak Co (NYSE: KODK) CEO Jim Continenza said Monday that the company would push ahead with making generic drug ingredients, irrespective of whether it receives government assistance or not,
With a pivot to Covid-19 drug making and scandalous allegations in view, traders should expect big moves in both directions in Kodak stock. The post Only the Bravest Among Us Should Consider a Positio
The Global Polyvinyl Butyral Market will grow by $ 1.28 bn during 2020-2024
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE